RegenVis

RegenVis

瑞吉维思

RegenVis

Biotech/Healthcare

RegiVerse Biotechnology (Shanghai), founded on November 29, 2021, is a biopharmaceutical company. It plans to begin safety evaluation and an IND filing for its first stem cell product.

Latest round: Angel Extension (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-09-11

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.